Page 34 – A3P – Pharmaceutical & Biotechnology Industry

La Vague 56

Cleaning and disinfection program part of the lifecycle approach: a risk based rather arbitrarily imposed approach

January 2018 La Vague n°56 Water Download the magazine Summary ✻ ASTM E2500 : let's cross the Bridge ! From study of the context to use of appropriate water treatment [...]

La Vague 56

A new water management strategy for the pharmaceutical industry.

January 2018 La Vague n°56 Water Download the magazine Summary ✻ ASTM E2500 : let's cross the Bridge ! From study of the context to use of appropriate water treatment [...]

La Vague 56

From study of the context to use of appropriate water treatment technologies

January 2018 La Vague n°56 Water Download the magazine Summary ✻ ASTM E2500 : let's cross the Bridge ! From study of the context to use of appropriate water treatment [...]

La Vague 56

ASTM E2500 : let’s cross the Bridge !

January 2018 La Vague n°56 Water Download the article Summary ✻ ASTM E2500 : let's cross the Bridge ! From study of the context to use of appropriate water treatment [...]

La Vague 56

Candida auris, an emerging pathogenic “killer” species

January 2018 La Vague n°56 Water Download the magazine Summary ✻ ASTM E2500 : let's cross the Bridge ! From study of the context to use of appropriate water treatment [...]

Company directory

VALIDAPRO EUROPE

VALIDAPRO is a service provider for the pharmaceutical, biotechnology and medical device industries.

La Vague 55

Quality Metrics: Why do manufacturers not support the FDA initiative anymore?

October 2017 La Vague n°55 International Congress 2017 Download Summary ✻ Quality Metrics: Why do manufacturers not support the FDA initiative anymore? Endotoxin masking hold-time study parameter determination and performance [...]

La Vague 55

Optimizing Quality systems through a paradigm shift: Placing the Operator at the center of the systems

October 2017 La Vague n°55 International Congress 2017 Download Summary ✻ Quality Metrics: Why do manufacturers not support the FDA initiative anymore? Endotoxin masking hold-time study parameter determination and performance [...]

La Vague 55

Endotoxin masking hold-time study parameter determination and performance

October 2017 La Vague n°55 International Congress 2017 Download Summary ✻ Quality Metrics: Why do manufacturers not support the FDA initiative anymore? Endotoxin masking hold-time study parameter determination and performance [...]

La Vague 54

Cluster consolidation strategies for solid oral forms in multi-product establishments.

July 2017 La Vague n°54 Cleaning validation Summary & ArticlesDownload number Summary ✻ Cluster consolidation strategies for solid oral forms in multi-product establishments Biocidal regulations applied to the disinfectants used [...]